Biggest News Aggregation in the World
📰 Inflammatory Disorders News

Page 2 - Inflammatory Disorders News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Inflammatory Disorders. Real-time updates on events, politics, business and more.

Tezspire approved for self-administration in the EU in a new pre-filled pen

Tezspire approved for self-administration in the EU in a new pre-filled pen New administration option for first and only severe asthma biologic approved in the EU with no phenotype or biomarker limitations AstraZeneca’s Tezspire (tezepelumab) has received a positive opinion from the Europea...
Lymphopoietin Isoforms Astrazeneca Tezspire Ian Pavord Tezepelumab Pharmacokinetics Clin Thera Tolerability After Administration

InsightAce Analytic Pvt. Ltd: Clinical Trial Planning and Design Services Market is Projected to Grow at a CAGR of 8.27%, During the Period 2022-2030, claims InsightAce Analytic

JERSEY CITY, N.J., Nov. 22, 2022 /PRNewswire/ -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on "Global Clinical Trial Planning and Design Services Market
United States South Africa Soult Ukpyolsi South Korea New Zealand Kostenloser Wertpapierhandel

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

How Multimodal Imaging Helps Differentiate Between Mechanisms of Outer Retinal Damage

A recent study published in Diagnostics identifies multimodal imaging traits to distinguish primary inflammatory choriocapillaropathies, such as multiple evanescent white dot syndrome and idiopathic multifocal choroiditis, from primary photoreceptoritis.
Laura Thomson Usman Ahmedsep Usman Ahmed Research Findings Centre For Ophthalmic Specialized Inflammatory Diseases

First and only biologic recommended for EU approval in patients with severe asthma with no phenotype or biomarker limitations

AstraZeneca’s Tezspire (tezepelumab) has been recommended for marketing authorisation in the European Union (EU) as an add-on therapy in patients 12 years and older with severe asthma who are inadequately controlled with high dose inhaled corticosteroids plus another medicinal product for maintenance treatment. The ...
United States United Kingdom Lymphopoietin Isoforms Astrazeneca Tezspire Pneumologie Mainz Thoraxklinik Heidelberg

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science